首页
>>
产品中心
>>
蛋白产品
>>
重组蛋白
>
Recombinant Human CD161/KLRB1 Protein, N-hFc

Recombinant Human CD161/KLRB1 Protein, N-hFc

产品编号

KMH344

别名

KLRB1抗原, NKR, CD161, CLEC5B, NKR P1, NKRP1A, NKR P1A, hNKR P1A, killer cell lectin like receptor B1

规格
  • 20ug
  • 50ug
  • 100ug
  • 200ug
  • 1mg
产品介绍
Catalog NumberKMH344
AliasKLRB1抗原, NKR, CD161, CLEC5B, NKR P1, NKRP1A, NKR P1A, hNKR P1A, killer cell lectin like receptor B1
Size20ug, 50ug, 100ug, 200ug, 1mg
Product DescriptionKMH344 Recombinant Human CD161/KLRB1 Protein, N-hFc contains the human KLRB1(68-225 aa) was expressed in Mammalian cells.
Molecular NameKLRB1
Product Introduction (KMH344) KLRB1是自然杀伤细胞的受体,调节免疫细胞的活性。
Molecular Weight58-70 kDa
Expression SystemHEK293F Cells
SpeciesHuman
Concentration联系销售经理获得最新批次的浓度
Purity≥95%
PurificationAffinity Purification
Uniprot IDQ12918
Storage ConditionStore the product under sterile conditions after opening at -80℃ for 12 months. Store the lyophilized powder at -20℃. Avoid repeated freeze-thaw cycles.
FormulationPBS
Shipping ConditionThis product is shipped on ice packs or dry ice.
BackgroundKLRB1 is a receptor found on natural killer cells, involved in immune cell recognition and response.
Endotoxin< 0.1 EU per ug
Protein FamilyCD molecule
Biological ActivityMeasured by its binding ability in a functional ELISA. When Recombinant Human CD161 Fc Chimera is coated at 5 μg/mL (100 μL/well), the concentration of recombinant human CLEC-2A Fc Chimera that produces 50% optimal binding response is found to be approxim
Product Declaration该产品仅供科研使用,不可直接用于人体或注射。
FAQ
  • 已表达的蛋白能否用于疫苗开发?

    是的,重组蛋白可以用于疫苗的开发,特别是在生产抗原性蛋白和研究免疫反应方面。

登录

还没有账号?立即注册

注册

已有账号?立即登录

立即询价